Ovid Therapeutics (OVID)
Ovid Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
18.1M
Short interest
settlement 2026-10-15
12.6
Days to cover
+3.6 days vs prior
40.8%
Short share of volume
2026-11-02
388
Fails to deliver
settlement 2026-10-14
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in OVID is 18,068,171 shares, down 3,083,008 shares over the last month. Over the last 48 readings it ranged from 488,729 shares (15 September 2025) to 22,039,852 shares (15 July 2026). At the reported average volume of 1.4M shares a day that is 12.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ovid" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 18,068,171 | -4.6% | 1,437,043 | 12.57 |
| 2026-09-30 | 18,948,082 | -10.4% | 2,122,356 | 8.93 |
| 2026-09-15 | 21,151,179 | +2.3% | 1,226,403 | 17.25 |
| 2026-08-31 | 20,674,725 | -4.4% | 1,576,338 | 13.12 |
| 2026-08-14 | 21,636,407 | +0.8% | 1,425,283 | 15.18 |
| 2026-07-31 | 21,462,926 | -2.6% | 1,532,367 | 14.01 |
| 2026-07-15 | 22,039,852 | +0.2% | 1,741,963 | 12.65 |
| 2026-06-30 | 21,998,879 | +85.6% | 5,823,749 | 3.78 |
| 2026-06-15 | 11,855,450 | +11.5% | 1,767,484 | 6.71 |
| 2026-05-29 | 10,632,208 | +5.4% | 1,260,258 | 8.44 |
| 2026-05-15 | 10,091,554 | +18.4% | 2,205,900 | 4.57 |
| 2026-04-30 | 8,527,074 | +22.6% | 1,920,664 | 4.44 |
| 2026-04-15 | 6,957,013 | -25.5% | 4,102,471 | 1.70 |
| 2026-03-31 | 9,337,824 | +71.2% | 6,101,520 | 1.53 |
| 2026-03-13 | 5,454,309 | +7.1% | 2,596,521 | 2.10 |
| 2026-02-27 | 5,090,831 | -2.1% | 703,732 | 7.23 |
| 2026-02-13 | 5,201,016 | +7.4% | 1,427,237 | 3.64 |
| 2026-01-30 | 4,840,700 | +0.4% | 1,848,363 | 2.62 |
| 2026-01-15 | 4,820,308 | +9.9% | 1,378,337 | 3.50 |
| 2025-12-31 | 4,384,071 | +5.0% | 1,675,937 | 2.62 |
| 2025-12-15 | 4,174,573 | +8.1% | 1,554,152 | 2.69 |
| 2025-11-28 | 3,861,388 | +10.3% | 1,930,179 | 2.00 |
| 2025-11-14 | 3,499,202 | +1.0% | 1,318,270 | 2.65 |
| 2025-10-31 | 3,465,773 | -9.5% | 1,655,192 | 2.09 |
| 2025-10-15 | 3,830,348 | +463.3% | 7,847,599 | 1.00 |
| 2025-09-30 | 680,035 | +39.1% | 2,626,824 | 1.00 |
| 2025-09-15 | 488,729 | -61.6% | 1,246,963 | 1.00 |
| 2025-08-29 | 1,274,152 | -15.7% | 1,666,833 | 1.00 |
| 2025-08-15 | 1,511,017 | -6.2% | 1,858,588 | 1.00 |
| 2025-07-31 | 1,610,117 | +54.2% | 3,570,120 | 1.00 |
| 2025-07-15 | 1,044,338 | -15.8% | 972,337 | 1.07 |
| 2025-06-30 | 1,240,950 | -50.3% | 2,156,059 | 1.00 |
| 2025-06-13 | 2,498,318 | +50.4% | 1,210,461 | 2.06 |
| 2025-05-30 | 1,660,818 | +2.0% | 544,929 | 3.05 |
| 2025-05-15 | 1,628,743 | +21.6% | 335,942 | 4.85 |
| 2025-04-30 | 1,339,819 | +11.7% | 454,666 | 2.95 |
| 2025-04-15 | 1,200,067 | -0.8% | 326,074 | 3.68 |
| 2025-03-31 | 1,210,381 | +13.7% | 567,716 | 2.13 |
| 2025-03-14 | 1,064,983 | +6.0% | 222,646 | 4.78 |
| 2025-02-28 | 1,004,689 | +1.4% | 339,930 | 2.96 |
| 2025-02-14 | 991,311 | +12.2% | 410,124 | 2.42 |
| 2025-01-31 | 883,735 | +25.3% | 548,841 | 1.61 |
| 2025-01-15 | 705,542 | +1.9% | 426,790 | 1.65 |
| 2024-12-31 | 692,039 | -27.0% | 357,095 | 1.94 |
| 2024-12-13 | 947,754 | +28.0% | 233,254 | 4.06 |
| 2024-11-29 | 740,283 | -2.1% | 202,312 | 3.66 |
| 2024-11-15 | 756,530 | +11.3% | 307,019 | 2.46 |
| 2024-10-31 | 679,890 | +12.0% | 103,906 | 6.54 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of OVID volume is 40.8%, down 24.7 points over the last five sessions. Over the last 30 readings it ranged from 23.9% (20 October 2026) to 79.2% (29 September 2026). The latest reading is 15.4 points below the 30-session average of 56.2%, on 849K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 347K | 849K | 40.8% | 20 |
| 2026-10-30 | 552K | 1.6M | 35.5% | 59,558 |
| 2026-10-29 | 316K | 703K | 45.0% | 1,200 |
| 2026-10-28 | 332K | 657K | 50.6% | 0 |
| 2026-10-27 | 208K | 542K | 38.4% | 1,311 |
| 2026-10-26 | 133K | 202K | 65.5% | 7,889 |
| 2026-10-23 | 452K | 633K | 71.3% | 32,841 |
| 2026-10-22 | 231K | 622K | 37.2% | 0 |
| 2026-10-21 | 1.0M | 1.8M | 55.9% | 4,923 |
| 2026-10-20 | 489K | 2.0M | 23.9% | 299 |
| 2026-10-19 | 310K | 475K | 65.3% | 400 |
| 2026-10-16 | 276K | 355K | 77.8% | 164 |
| 2026-10-15 | 298K | 563K | 53.0% | 0 |
| 2026-10-14 | 352K | 761K | 46.2% | 400 |
| 2026-10-13 | 322K | 551K | 58.4% | 0 |
| 2026-10-12 | 216K | 299K | 72.0% | 0 |
| 2026-10-09 | 244K | 623K | 39.2% | 0 |
| 2026-10-08 | 195K | 333K | 58.6% | 0 |
| 2026-10-07 | 241K | 487K | 49.6% | 0 |
| 2026-10-06 | 397K | 633K | 62.7% | 24 |
| 2026-10-05 | 258K | 435K | 59.3% | 0 |
| 2026-10-02 | 442K | 882K | 50.1% | 611 |
| 2026-10-01 | 293K | 395K | 74.2% | 0 |
| 2026-09-30 | 331K | 527K | 62.7% | 37 |
| 2026-09-29 | 289K | 364K | 79.2% | 496 |
| 2026-09-28 | 301K | 436K | 68.9% | 594 |
| 2026-09-25 | 326K | 422K | 77.3% | 506 |
| 2026-09-24 | 461K | 683K | 67.5% | 8,689 |
| 2026-09-23 | 1.0M | 1.5M | 71.4% | 12,183 |
| 2026-09-22 | 576K | 2.1M | 27.0% | 8,864 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in OVID is 388 shares, down 1,438 shares over the last settlement date. Over the last 30 readings it ranged from 13 shares (8 July 2026) to 3,670,365 shares (24 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 388 | $2.19 | $850 |
| 2026-10-06 | 1,826 | $2.34 | $4K |
| 2026-09-30 | 366 | $2.54 | $930 |
| 2026-09-22 | 4,202 | $2.71 | $11K |
| 2026-09-21 | 476,759 | $2.69 | $1.3M |
| 2026-09-18 | 30,673 | $2.70 | $83K |
| 2026-09-11 | 12,895 | $2.63 | $34K |
| 2026-09-02 | 23 | $2.76 | $63 |
| 2026-09-01 | 1,985 | $2.67 | $5K |
| 2026-08-31 | 16,186 | $2.80 | $45K |
| 2026-08-28 | 1,240 | $2.93 | $4K |
| 2026-08-20 | 4,238 | $2.93 | $12K |
| 2026-08-18 | 195,224 | $2.89 | $564K |
| 2026-08-13 | 1,714 | $2.62 | $4K |
| 2026-08-11 | 78 | $2.62 | $204 |
| 2026-08-07 | 376 | $2.65 | $996 |
| 2026-08-06 | 32,022 | $2.62 | $84K |
| 2026-08-04 | 47,000 | $2.33 | $110K |
| 2026-07-27 | 3,441,592 | $2.33 | $8.0M |
| 2026-07-24 | 3,670,365 | $2.40 | $8.8M |
| 2026-07-21 | 4,561 | $2.31 | $11K |
| 2026-07-20 | 4,005 | $2.44 | $10K |
| 2026-07-17 | 149 | $2.45 | $365 |
| 2026-07-09 | 8,201 | $2.73 | $22K |
| 2026-07-08 | 13 | $2.76 | $36 |
| 2026-07-02 | 648,539 | $2.68 | $1.7M |
| 2026-07-01 | 665,389 | $2.69 | $1.8M |
| 2026-06-30 | 1,002,241 | $2.72 | $2.7M |
| 2026-06-29 | 846,552 | $2.55 | $2.2M |
| 2026-06-26 | 35 | $2.42 | $85 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for OVID in the last 90 days. The most recent filings are listed below. Latest filing: Carter Charles Ross (Chief Financial Officer) on 2026-07-06.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Carter Charles Ross | Chief Financial Officer | Grant | 50K | $0.00 | $0 | 94K |
| 2026-04-07 | PAPADOPOULOS STELIOS | Director | Grant | 18K | $2.56 | $45K | 218K |
| 2026-04-07 | Friedman Bart | Director | Grant | 9K | $2.56 | $22K | 9K |
| 2026-04-07 | Fitzgerald Kevin Joseph | Director | Grant | 18K | $2.56 | $45K | 18K |
| 2026-03-23 | LEVIN JEREMY M | Executive Chairman | Exercise or conversion | 47K | $1.40 | $66K | 3.7M |
| 2026-02-26 | Rona Jeffrey A | CBFO | Grant | 68K | $0.00 | $0 | 156K |
| 2026-02-23 | Rona Jeffrey A | CBFO | Sell | 9K | $1.45 | $12K | 88K |
| 2026-02-23 | ALEXANDER MARGARET A. | President and CEO | Sell | 12K | $1.45 | $17K | 62K |
| 2025-12-15 | LEVIN JEREMY M | CEO | Conversion | 71K | price not stated in the filing | not stated | 3.7M |
| 2025-12-08 | Takeda Pharmaceuticals U.S.A., Inc. | TenPercentOwner | Conversion | 1.3M | $0.00 | $0 | 7.0M |
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD | 10% owner | Conversion | 1.3M | $0.00 | $0 | 7.0M |
| 2025-02-26 | Rona Jeffrey A | CBFO | Sell | 4K | $0.56 | $2K | 68K |
| 2025-02-26 | ALEXANDER MARGARET A. | President and COO | Sell | 5K | $0.56 | $3K | 73K |
| 2025-02-20 | ALEXANDER MARGARET A. | President and COO | Grant | 44K | $0.00 | $0 | 79K |
| 2025-02-20 | Rona Jeffrey A | CBFO | Grant | 44K | $0.00 | $0 | 72K |
| 2025-01-27 | ALEXANDER MARGARET A. | President and COO | Buy | 7K | $0.73 | $5K | 35K |
| 2024-03-18 | LEVIN JEREMY M | CEO | Buy | 18K | $2.76 | $50K | 3.6M |
| 2024-02-22 | Perone Thomas Michael | General Counsel, Secretary | Grant | 28K | $0.00 | $0 | 28K |
| 2024-02-22 | Rona Jeffrey A | CBFO | Grant | 28K | $0.00 | $0 | 28K |
| 2024-02-22 | Tardio Jason | Chief Operating Officer | Grant | 28K | $0.00 | $0 | 28K |
| 2023-12-04 | LEVIN JEREMY M | CEO | Gift | 573K | $0.00 | $0 | 4.2M |
| 2023-12-04 | LEVIN JEREMY M | CEO | Gift | 573K | $0.00 | $0 | 3.6M |
| 2022-09-12 | Tardio Jason | Chief Operating Officer | Sell | 17K | $2.15 | $37K | 0 |
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD | 10% owner | Other transaction | 5.8M | $0.00 | $0 | 5.8M |
| 2022-07-01 | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | Other transaction | 5.8M | $0.00 | $0 | 0 |
| 2021-07-14 | Rakhit Amit | President and CMO | Sell | 34K | $3.71 | $126K | 727K |
| 2021-07-14 | Rakhit Amit | President and CMO | Exercise or conversion | 34K | $1.89 | $64K | 761K |
| 2020-08-28 | LEVIN JEREMY M | CEO | Buy | 8K | $5.84 | $50K | 5.8M |
| 2019-09-20 | LEVIN JEREMY M | CEO | Gift | 465K | $0.00 | $0 | 0 |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for OVID worth $1.3M at the prices reported; 2 in the last 90 days worth $1.3M. Latest: Jeffrey A. Rona filed on 2026-08-24 to sell 325,000 shares ($910K) from 2026-08-24.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-24 | Jeffrey A. RonaAffiliated Stockholder | 325K | $910K | 0.166% | 2026-08-24 | Morgan Stanley |
| 2026-08-14 | Jeffrey A. RonaAffiliated Stockholder | 150K | $420K | 0.077% | 2026-08-14 | Morgan Stanley |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON18 holders report 5% or more of OVID in their latest filing, all on Schedule 13G (passive). The largest reported stake is Takeda Pharmaceutical Company Limited at 12.3% of the class (8,781,996 shares), filed 2025-12-09 for an event on 2025-12-08.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Eventide Asset Management, LLCinvestment adviser | 11.8M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Finny Kuruvilla, M.D., Ph. D.parent holding company, individual | 11.8M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Robin C. Johnparent holding company, individual | 11.8M | 6.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | RA Capital Healthcare Fund, L.P.partnership | 19.5M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | RA Capital Management, L.P.investment adviser, partnership | 19.5M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Peter Kolchinskyparent holding company, individual | 19.5M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Rajeev Shahparent holding company, individual | 19.5M | 9.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Dmitry Balyasnyparent holding company, individual | 9.3M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | BALYASNY ASSET MANAGEMENT L.P.investment adviser, partnership | 9.3M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | BAM GP LLCparent holding company, other entity | 9.3M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Balyasny Asset Management Holdings LPparent holding company, partnership | 9.3M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Dames GP LLCparent holding company, other entity | 9.3M | 5.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Daniel Schneebergerparent holding company, individual | 9.6M | 5.1% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | ADAR1 Capital Management, LLCinvestment adviser, other entity | 9.6M | 5.1% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | ADAR1 Capital Management GP, LLCother entity | 9.1M | 4.9% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 3 | Affinity Asset Advisors, LLCinvestment adviser, other entity | 15.1M | 7.9% | 2026-06-30 |
| 2026-08-13 | 13G/Ano. 3 | Michael Choindividual, parent holding company | 15.1M | 7.9% | 2026-06-30 |
| 2026-07-29 | 13G | BlackRock, Inc.parent holding company | 10.8M | 5.8% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | J. Christopher Donahueindividual | 7.7M | 4.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Ann C. Donahueindividual | 7.7M | 4.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Thomas R. Donahueindividual | 7.7M | 4.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Voting Shares Irrevocable Trustother entity | 7.7M | 4.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | Federated Hermes, Inc.parent holding company | 7.7M | 4.2% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 1.9M | 1.3% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 1.9M | 1.3% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Steven A. Cohenindividual | 1.9M | 1.3% | 2026-03-31 |
| 2026-05-15 | 13G | Alex Silversteinparent holding company, individual | 18.0M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G | Sirenia Capital Management LPinvestment adviser, partnership | 18.0M | 9.9% | 2026-03-31 |
| 2026-05-14 | 13G/Ano. 6 | Jeremy M. Levinindividual | 8.6M | 4.5% | 2026-03-31 |
| 2025-12-18 | 13G | Affinity Healthcare Fund, LPpartnership | 12.1M | 9.0% | 2025-12-11 |
| 2025-12-09 | 13G/Ano. 4 | Takeda Pharmaceutical Company Limitedcorporation | 8.8M | 12.3% | 2025-12-08 |
| 2025-12-09 | 13G/Ano. 4 | Takeda Pharmaceutical U.S.A., Inc.corporation | 7.0M | 9.8% | 2025-12-08 |
| 2025-12-08 | 13G | JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company | 7.1M | 10.0% | 2025-11-28 |
13F holders
Tracked managers holding OVID at their latest 13F. JSON5 of the 30 tracked managers held OVID at their latest 13F, $7.9M in total at quarter-end prices. Point72 Asset Management is the largest at $5.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 1.9M | $5.2M | 0.01% | +625K |
| Two Sigma Investments | 2026-06-30 | 832K | $2.2M | 0.00% | -424K |
| Renaissance Technologies | 2026-06-30 | 106K | $284K | 0.00% | -999K |
| D. E. Shaw & Co. | 2026-06-30 | 37K | $99K | 0.00% | new |
| Millennium Management | 2026-06-30 | 32K | $87K | 0.00% | -1.5M |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Ovid Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Ovid Therapeutics (OVID), SEC CIK 1636651, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-24.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-03-18.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-06.JSON and CSV
- Company record
- EDGAR filing index for CIK 1636651Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of OVID is sold short?
What is OVID's daily short volume?
Does OVID have fails to deliver?
Are OVID insiders buying or selling?
Have OVID insiders filed to sell?
Who owns 5% or more of OVID?
Which tracked 13F managers own OVID?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.